Anavex Life Sciences Corp (AVXL)

[falconer66a]

Better than the first announcement.

For sure, the release of the Parkinson's disease dementia(PDD) study at the big Alzheimer's conference is significant; will result in all sorts of new things.

Earlier, Dr. Missling's mention of "statistically significant" data in the PDD trial sealed the deal for me; before today's announcement. Missling has a PhD in science; knows what stat sig means and implies. He didn't arbitrarily speak of it. It was deliberate, real, as are, now, the therapeutic outcomes blarcamesine evokes.

But, today, having the PDD results revealed at a big Alzheimer's conference is even bigger. People who want to dismiss Anavex and blarcamesine, whether on this board, in doctor's lounges in hospitals, or over lunch tables in research labs, are, now, going to have a hard story to tell. The drug actually works, safely and effectively. The diehard naysayers can continue to lay out all of their objections, but, now, they are utterly irrelevant.

Can't beat actual clinical success. Detailed understanding of biochemistry involved in the MOA (mechanism of action) is no longer relevant. "Wait a minute. Is this 'blarcamesine' stuff safe? Can it really turn off or prevent dementia?" After the CTAD event, the Anavex case is closed. For CNS diseases, a new therapeutic era is about to start.